Supplementary Table 4: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study

Name: Supplementary Table 4: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study
Creator: Taylor & Francis
Published: 2024-05-17 00:00:00
License: 暂无描述

future-science-group.figshare.com2024-05-17 更新2025-03-26 收录

下载链接：

https://future-science-group.figshare.com/articles/dataset/Supplementary_Table_4_Tanezumab_for_chronic_low_back_pain_a_long-term_randomized_celecoxib-controlled_Japanese_Phase_3_safety_study/17040287/1

下载链接

链接失效反馈

官方服务：

资源简介：

Supplementary Table 4. Tanezumab for Chronic Low Back Pain: A Long-term, Randomized, Celecoxib-Controlled, Japanese, Phase 3, Safety Study Summary of TEAEs of possible decreased sympathetic function through week 80 (treatment + follow-up periods)

补充表格4. 坦能舒布用于慢性下背痛：一项为期长期、随机、塞来昔布对照、日本、3期、安全性研究通过第80周（治疗+随访期）可能的副反应总结，探讨交感神经功能降低的可能性

提供机构：

Taylor & Francis